Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01313897
Title UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma (NK2010-35)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Arkansas
Indications

multiple myeloma

Therapies

Bortezomib

Age Groups: adult
Covered Countries USA


No variant requirements are available.